Elsevier,
The Lancet Regional Health - Europe, Volume 45, October 2024
Analysis of the research used as a basis for clinical guideline development underscores the insufficient consideration of sex and gender in the primary evidence base informing the 2019 ESC guideline recommendations for chronic coronary syndromes. The underrepresentation of women in cardiovascular research and guideline development poses challenges for accurately discerning possible sex- and gender-specific effects and tailoring recommendations to diverse patient needs. Addressing these gaps requires explicitly integrating sex and gender considerations into study designs and guideline creation processes and promoting inclusivity to optimize clinical care provision and improve outcomes for all individuals affected by ischemic heart diseases.
Elsevier,
The Lancet Regional Health - Europe, Volume 45, October 2024
The number of women referred to a clinic with pregnancy-associated cancer will increase as NIPT providers will be able to better recognize malignant-suspicious NIPT from foetal aneuploidy screening. Reporting malignancy suspicious-NIPT results may be a step forward in detecting cancers and could enable an earlier diagnosis and start of cancer therapy, especially for haematological malignancies and advanced solid tumours.
Elsevier,
The Lancet Rheumatology, Volume 6, September 2024
This Article supports SDG 3 by comprehensively estimating the burden of low back pain by considering the effects of health-care interventions on health state severity distribution; the authors show that the burden of low back pain in low-income and middle-income countries has been underestimated in GBD, but also that this higher burden is amenable to improved access to treatment.